missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Gibco™ Human Apo-SAA1 Recombinant Protein, PeproTech®
Click to view available options
Quantité:
10 μg
100 μg
2 x 500 μg
250 μg
50 μg
500 μg
Conditionnement:
100µg
10µg
1mg
250µg
500µg
50µg
Description
300-53-1MG will be provided as 2 x 500 μg (300-53-500UG). Recombinant Human Apo-SAA1 is an 11.7 kDa protein containing 105 amino acid residues. This product is shipped at ambient temperature. For storage, handling and reconstitution information, please see the lot-specific Certificate of Analysis
The serum amyloid A family comprises a number of differentially expressed apolipoproteins, acute-phase SAA1 and SAA2, the former being the major component in plasma and constitutive SAAs. Although the liver is the primary site of synthesis of both SAA types extrahepatic production has been reported. The in vivo concentrations increase by as much as 1000 fold during inflammation. Several studies have expressed its importance in the diagnosis and monitoring of various diseases. Pathological SAA values are often detected in association with normal CRP concentrations; SAA rises earlier and more sharply than CRP. Recently, a broader view of SAA expression and function has been emerging.
Spécification
Spécification
| Numéro d’adhésion | P0DJI8 |
| À utiliser avec (application) | Functional Assay |
| Formule | protein with no preservative |
| Identification génétique (Entrez) | 6288 |
| Poids moléculaire | 11.7 kDa |
| Nom | Human Apo-SAA1 |
| Quantité | 100 μg |
| Source | E. coli |
| État réglementaire | RUO |
| Concentration en endotoxines | <1 EU/ μg |
| Afficher plus |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu